Ultra-Late Osteosarcoma Recurrences: An Analysis of 17 Cooperative Osteosarcoma Study Group Patients with a First Recurrence Detected More Than 10 Years After Primary Tumor Diagnosis

被引:2
|
作者
Hecker-Nolting, Stefanie [1 ]
Kager, Leo [2 ,3 ]
Kuhne, Thomas [4 ]
Baumhoer, Daniel [5 ,6 ]
Blattmann, Claudia [1 ]
Friedel, Godehard [7 ]
von Kalle, Thekla [8 ]
Kevric, Mathias [1 ]
Mayer-Steinacker, Regine [9 ]
Schwarz, Rudolf [10 ]
Sorg, Benjamin [1 ]
Wirth, Thomas [11 ]
Bielack, Stefan S. [1 ,12 ]
机构
[1] Klinikum Stuttgart, Ctr Pediat Adolescent & Womens Med, Stuttgart Canc Ctr, Cooperat Osteosarcoma Study Grp,Olgahosp,Pediat 5, Kriegsbergstr 62, D-70174 Stuttgart, Germany
[2] Med Univ Vienna, Dept Pediat, Vienna, Austria
[3] St Anna Childrens Hosp, St Anna Childrens Canc Res Inst CCRI, Vienna, Austria
[4] Univ Childrens Hosp Basel, Dept Oncol Hematol, Basel, Switzerland
[5] Univ Hosp Basel, Inst Med Genet & Pathol, Bone Tumor Reference Ctr, Basel, Switzerland
[6] Univ Basel, Basel, Switzerland
[7] Univ Hosp Tuebingen, Clin Thorac Heart & Vasc Surg, Tubingen, Germany
[8] Klinikum Stuttgart, Radiol Inst, Ctr Pediat Adolescent & Womens Med, Stuttgart Canc Ctr,Olgahosp, Stuttgart, Germany
[9] Ulm Univ Hosp, Dept Internal Med, Div Hematol & Oncol, Ulm, Germany
[10] Univ Med Ctr Eppendorf, Dept Radiat Oncol, Hamburg, Germany
[11] Klinikum Stuttgart Olgahosp, Stuttgart Canc Ctr, Ctr Pediat Adolescent & Womens Med, Dept Orthopaed, Stuttgart, Germany
[12] Univ Childrens Hosp Muenster, Dept Pediat Hematol & Oncol, Munster, Germany
关键词
osteosarcoma; recurrence; metastases; chemotherapy; surgery; radiotherapy; PROGNOSTIC-FACTORS; CHEMOTHERAPY; EXTREMITIES; SURVIVAL; RELAPSE;
D O I
10.1089/jayao.2021.0221
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Osteosarcoma is a typical malignancy of childhood and adolescence. Recurrences usually occur early, but rarely may arise after decades of remission. Little is known about these very late events and we set out to fill this knowledge gap.Methods: The database of the Cooperative Osteosarcoma Study Group (COSS) was searched for patients with a first recurrence of a high-grade central osteosarcoma occurring >10 years after diagnosis of the primary disease. Identified patients were analyzed for demographic, tumor-, and treatment-related factors as well as outcomes.Results: Among a total of 1,178 10-year relapse-free survivors, 17 affected patients were identified. Only five of these had a documented good response to initial chemotherapy. No presenting factor was identified to predict these very late events. Prognosis was generally very poor despite intensive multimodal therapy. Inoperability of the recurrences seems to have constituted a major limiting factor.Conclusion: Osteosarcoma patients should be followed for potential recurrences for well >10 years from initial diagnosis. Only through such an extended truly long-term follow-up and a structured transition of young patients can these be detected while they are still operable and, hence, potentially curable.
引用
收藏
页码:76 / 82
页数:7
相关论文
共 1 条
  • [1] The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols
    Andreou, D.
    Bielack, S. S.
    Carrle, D.
    Kevric, M.
    Kotz, R.
    Winkelmann, W.
    Jundt, G.
    Werner, M.
    Fehlberg, S.
    Kager, L.
    Kuehne, T.
    Lang, S.
    Dominkus, M.
    Exner, G. U.
    Hardes, J.
    Hillmann, A.
    Ewerbeck, V.
    Heise, U.
    Reichardt, P.
    Tunn, P. -U.
    ANNALS OF ONCOLOGY, 2011, 22 (05) : 1228 - 1235